Monday , October 23 2017
Home / Letter From The Editor / Editor’s Note, DCMS #245

Editor’s Note, DCMS #245

This morning I had a new PharmD candidate start a rotation with me. As is customary with all my interns, I spent the first few hours getting them out of "textbook/multiple choice" mode and into "patient care" mode. During the conversation I often pick one drug and we have a down-to-basics discussion. This time we focused on Symlin (pramlintide) the synthetic version of the alpha cell-produced hormone amylin. If you have not thought about that drug in a while then you will want to check out this week’s Homerun Slides and see how this medication still might be a good choice for your insulin-using patients.

The Clinical Text continues to explore treating eye problems, while our Disaster Averted lends some insight into how you may be able to keep a patient adherent on a new medication. Our Mastery In Minutes video interview looks at why sticking ten diabetes patients in a room and making them all do the same thing never works.